Invention relates to a novel nutraceutical products isolated and characterized from Moringa oleifera. The process involves the cold extraction of moringa seeds, which gives five different nutraceutical ingredients. This invention describes the nutraceutical and pharmaceutical activity of the products which have been isolated by a series of extraction techniques. One of the products extracted in such process is a complex characterized to be a type of glucosinolate combined with cationic protein, which is found to be very active against diabetes. The other product extracted can be used for wound healing.
Technologies